ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Merus NV

Merus NV (2GH)

41.40
-2.00
(-4.61%)
Closed 06 December 8:00AM
Realtime Data

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
41.40
Bid
41.00
Offer
42.00
Volume
542
43.20 Day's Range 43.80
21.40 52 Week Range 58.50
Previous Close
43.40
Open
43.80
Last Trade
47
@
43.2
Last Trade Time
Average Volume (3m)
114
Financial Volume
-
VWAP
-

2GH Latest News

Merus Announces FDA Approval of BIZENGRI® (zenocutuzumab-zbco) for NRG1+ Pancreatic Adenocarcinoma and NRG1+ Non–Small Cell Lung Cancer (NSCLC) Based on Safety and Efficacy Data From the eNRGy Study

Merus Announces FDA Approval of BIZENGRI® (zenocutuzumab-zbco) for NRG1+ Pancreatic Adenocarcinoma and NRG1+ Non–Small Cell Lung Cancer (NSCLC) Based on Safety and Efficacy Data From the eNRGy...

Merus and Partner Therapeutics Announce License Agreement for the U.S. Commercialization of Zenocutuzumab in NRG1 Fusion-Positive Cancer

Merus and Partner Therapeutics Announce License Agreement for the U.S. Commercialization of Zenocutuzumab in NRG1 Fusion-Positive Cancer UTRECHT, The Netherlands and CAMBRIDGE, Mass., Dec. 02...

Merus et Partner Therapeutics annoncent un contrat de licence en vue de la commercialisation aux États-Unis du zenocutuzumab dans le cadre du traitement des cancers à fusion NRG1 positive

Merus et Partner Therapeutics annoncent un contrat de licence en vue de la commercialisation aux États-Unis du zenocutuzumab dans le cadre du traitement des cancers à fusion NRG1 positive UTRECHT...

Merus und Partner Therapeutics geben Lizenzvereinbarung für die Vermarktung von Zenocutuzumab in den USA bei NRG1-fusionspositivem Krebs bekannt

Merus und Partner Therapeutics geben Lizenzvereinbarung für die Vermarktung von Zenocutuzumab in den USA bei NRG1-fusionspositivem Krebs bekannt UTRECHT, Niederlande, und CAMBRIDGE, Massachusetts...

Merus gibt am ESMO-Kongress 2024 in Asien die Veröffentlichung eines Abstracts zur Behandlung von rezidivierenden/metastasierten Kopf- und Halstumoren ab der zweiten Behandlungslinie mit Petosemtamab bekannt

Merus gibt am ESMO-Kongress 2024 in Asien die Veröffentlichung eines Abstracts zur Behandlung von rezidivierenden/metastasierten Kopf- und Halstumoren ab der zweiten Behandlungslinie mit...

Merus annonce la publication d’un résumé sur le pétosemtamab en tant que traitement de 2e ligne et au-delà pour le CETC r/m lors de l’édition 2024 du Congrès de l’ESMO Asia

Merus annonce la publication d’un résumé sur le pétosemtamab en tant que traitement de 2e ligne et au-delà pour le CETC r/m lors de l’édition 2024 du Congrès de l’ESMO Asia – Les données...

Merus Announces Publication of an Abstract on Petosemtamab as 2L+ treatment of r/m HNSCC at the ESMO Asia Congress 2024

Merus Announces Publication of an Abstract on Petosemtamab as 2L+ treatment of r/m HNSCC at the ESMO Asia Congress 2024 – Petosemtamab 1500 mg monotherapy phase 2 interim data continues to...

Merus annonce sa participation aux prochaines journées Investisseurs

Merus annonce sa participation aux prochaines journées Investisseurs UTRECHT, Pays-Bas et CAMBRIDGE, État du Massachusetts, 07 nov. 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq : MRUS), une...

Merus hält Vorträge auf bevorstehenden Investorenkonferenzen

Merus hält Vorträge auf bevorstehenden Investorenkonferenzen UTRECHT, Niederlande und CAMBRIDGE, Massachusetts, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS), ein Unternehmen aus...

La FDA octroie à Merus un report de la date PDUFA pour le zénocutuzumab

La FDA octroie à Merus un report de la date PDUFA pour le zénocutuzumab UTRECHT, Pays-Bas et CAMBRIDGE, Massachusetts, 05 nov. 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq : MRUS), ci-après...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-1.8-4.1666666666743.247437546.60089286DE
4-8.6-17.25051.540.49946.46118598DE
12-4-8.8105726872245.451.540.411447.6509915DE
26-5.2-11.158798283346.657.540.415348.80237835DE
5220.00000193.457952965321.39999958.521.39999917044.3573342DE
15617.673.949579831923.858.51916541.98058262DE
26017.673.949579831923.858.51916541.98058262DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
17DArcadia Biosciences Inc
5.15 €
(99.61%)
10.94k
1KPAProtara Therapeutics Inc
5.90 €
(75.60%)
16.79k
1ZY0Medaro Mining Corp
0.17 €
(63.46%)
54.1k
TE9Teco 2030 ASA
0.0398 €
(61.79%)
1.04M
L7C2Windfall Geotek Inc
0.006 €
(50.00%)
18k
NL8Genesis Ai Corp
0.0056 €
(-58.82%)
10k
0PV2Moovly Media Inc
0.0025 €
(-58.33%)
859
CNWCodon AG
0.0065 €
(-40.91%)
1.5k
BLEBluebird bio Inc
0.4205 €
(-40.13%)
233.06k
DW8Tantalex Lithium Resources Corp
0.0115 €
(-39.47%)
2k
D7GNel ASA
0.2679 €
(0.15%)
5.5M
AXIAtos SE
0.20 €
(-36.51%)
4.95M
PLUNPlug Power Inc
2.2955 €
(13.55%)
3.17M
R9BDeFi Technologies Inc
3.06 €
(-6.13%)
2.98M
TUI1Tui AG
8.318 €
(5.26%)
2.21M

Discussion

View Full Feed
Zardiw Zardiw 5 minutes ago
$TORVF has ZERO conv debt. They use Private Placements...which is Restricted Stock

Z
TORVF
stockinspector stockinspector 5 minutes ago
Why don't you /insert words here/ss?
P.S. your english is getting somewhat better!
WDLF
Lime Time Lime Time 5 minutes ago
Sell at the right time and buy at the right time. That's all you need to do. This one ain't going any lower 🚀
GVSI
Deano361 Deano361 5 minutes ago
As long as shell status,  restricted stay that way so float is low as before almost 
FUNR
Tadaaa Tadaaa 6 minutes ago
Bonzo Finance Partners with LWorks to Launch DeFi Lending on Hedera

https://www.tmcnet.com/usubmit/2024/12/05/10116314.htm
HBARUSD
Tadaaa Tadaaa 8 minutes ago
Hedera News: Diamond Standard Revolutionizes Market with Tokenized Diamonds

https://www.crypto-news-flash.com/hedera-news-diamond-standard-revolutionizes-market-with-tokenized-diamonds/
HBARUSD
Carjockey2 Carjockey2 8 minutes ago
So you swallowed??

>>>Hawk coin has spit-on-my-dick value😂
Zardiw Zardiw 10 minutes ago
I think there's a similarity here.......Wonder how many people will see $TORVF as a great opportunity here........or pass on it and regret it later.....lol

Z
TORVF
Deano361 Deano361 11 minutes ago
New ticker? 
trader59 trader59 12 minutes ago
I'd expect he may have seen one revoked that came back, but in that case the company remained in business and eventually re-registered. I've seen one bankrupt OTC company that continued to trade even after the company was shut down that got hijacked and used for a pump and dump, and another that wa
LowFloatLopes LowFloatLopes 13 minutes ago
Volume then price ;) 
AZRH
Real McCoy Real McCoy 13 minutes ago
Well you’re obviously out 100%. So what you got given that?
alertmeipp alertmeipp 14 minutes ago
Hopefully, the pay off will compensate for it. Maybe we will wake up one day and see a buyout offer for a billion or two.
ENTA
Hi_Lo Hi_Lo 16 minutes ago
No reward without risk.

Just like people got rewarded with SONG?

https://investorshub.advfn.com/uimage/uploads/2024/12/5/l[uciScreenshot_20241205_191319_Chrome.jpg
BCAP
rickstereo3333 rickstereo3333 16 minutes ago
I honestly have no real clue but looking at this openly, that could be one of several possibilities...................AIMHO



1) Radiogel data provided by Vivos has not yet sufficiently impressed the FDA enough for them to grant IDE so additional info keeps being reques
HED
budfoxfun budfoxfun 17 minutes ago
The Sustainable Green Team https://thesustainablegreenteam.com/sgtm-blog/f/tony-raynor-founder-and-ceo-of-the-sustainable-green-team?blogcategory=SGTM+Leadership
SGTM
SilkRoad SilkRoad 18 minutes ago
patrik, when the first batch of silk is sold I think you’ll be very happy. Psssssst, just between us, I think it’s already sold. It’s just a matter of making the specific amount and collecting the money.
KBLB
budfoxfun budfoxfun 18 minutes ago
The Microbe Living Mulch aids in carbon sequestration, improves soil health, and ensures better moisture retention, promoting a sustainable and vibrant outdoor environment. https://thesustainablegreenteam.com/living-mulch%C2%AE
SGTM
alertmeipp alertmeipp 19 minutes ago
We all think BoD got us awful price but the odd thing is so far no one other than Crown willing to buy RVNC out. Otherwise, Crown won’t have a chance to take so long to squeeze Foley.
RVNC
AlwaysKing AlwaysKing 19 minutes ago
$RDAR ~Right now we are sitting at a measly $5.7 million market cap which means we have much room to fly very high from this super undervalued price point! It's only a matter of time before we meet up with the true market evaluation for a company of this magnitude which is easily copper or even si
RDAR
RichieBoy RichieBoy 20 minutes ago
Send your resume, what harm can it do.

Seriously.
AFFU
doughnuthole doughnuthole 20 minutes ago
I think someone said we could do anonymous reports... It just depends on if it matters enough. I'll prolly call them but I won't be filling out a report. I also asked him if he's ever seen a dead stock like this rise from the grave and he said he's seen it once. Insert Jim Carrey meme so you're tell
space1230 space1230 22 minutes ago
Hey boy genius, the new company already addressed that they have the financial report and r waiting for OTCM access. It's a common delay with ownership transfers and entirely the fault of OTCM. Yet u r posting OTC warnings like the company has been negligent. Read some of the posts once in a while
OTCM
bones jones bones jones 22 minutes ago
I know considering that my first purchase was over a penny I now have average of 0052. I'm hopeful JFHE is going to deliver in 2025-26, I really think this is a one in a lifetime opportunity for the patient. Good things come to those who wait. Also Rdar.
Not pumping just my belief.
IGPK

Your Recent History

Delayed Upgrade Clock